Keloid or Hypertrophic Scar: The Controversy: Review of the Literature

Keloid and hypertrophic scars are 2 types of excessive scarring observed clinically that require different therapeutic approaches. The clinical course and physical appearance define keloids and hypertrophic scars as separate entities; however, they are often confused because of an apparent lack of morphologic differences. Nevertheless, clinical differences between hypertrophic scars and keloids have long been recognized by plastic surgeons and dermatologists. Yet, translating these differences into morphologic or biochemical distinctions has prompted much conflict in the literature. The present report is an attempt to clarify the longstanding controversy regarding these 2 similar yet separate and nonidentical entities by highlighting the reported points of differentiation as well as the similarities.

[1]  Wei Chen,et al.  [Relationship of overexpression of angiogenesis factors and their receptors with invasive growth of keloid]. , 2004, Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery.

[2]  W. Blackburn,et al.  Histologic basis of keloid and hypertrophic scar differentiation. Clinicopathologic correlation. , 1966, Archives of pathology.

[3]  M. Longaker,et al.  Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. , 2001, Plastic and reconstructive surgery.

[4]  M. Tenenhaus,et al.  Alterations in Fibroblast α1β1 Integrin Collagen Receptor Expression in Keloids and Hypertrophic Scars , 2002 .

[5]  S. Miyagawa,et al.  Expression of p53 family in scars. , 2004, Journal of dermatological science.

[6]  Luís Cristóvão Porto,et al.  Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. , 2003, Pathology, research and practice.

[7]  W. Sahl,et al.  CUTANEOUS SCARS: PART I , 1994, International journal of dermatology.

[8]  T. Tuan,et al.  The molecular basis of keloid and hypertrophic scar formation. , 1998, Molecular medicine today.

[9]  G. Saed,et al.  p53 and apoptosis alterations in keloids and keloid fibroblasts , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[10]  S. Pollack,et al.  The surgical treatment of keloids. , 1982, The Journal of dermatologic surgery and oncology.

[11]  F. Verrecchia,et al.  5-fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase/activator protein-1 activation. , 2003, Molecular pharmacology.

[12]  Chao-Chun Yang,et al.  Histopathological Differential Diagnosis of Keloid and Hypertrophic Scar , 2004, The American Journal of dermatopathology.

[13]  A Bayat,et al.  Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. , 2002, British journal of plastic surgery.

[14]  J. Uitto,et al.  Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. , 2000, Journal of dermatological science.

[15]  T. Sugihara,et al.  Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. , 2000, The American journal of pathology.

[16]  E. Peacock,et al.  Biologic basis for the treatment of keloids and hypertrophic scars. , 1970 .

[17]  Kischer Cw.  Comparative ultrastructure of hypertrophic scars and keloids. , 1984 .

[18]  A. Rekha.  Keloids – a frustrating hurdle in wound healing , 2004, International wound journal.

[19]  Edmond Sabo,et al.  Intralesional Cryotherapy for Enhancing the Involution of Hypertrophic Scars and Keloids , 2003, Plastic and reconstructive surgery.

[20]  J. Russell,et al.  Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M Kon,et al.  On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.

[22]  R. Wb,et al.  Keloids and hypertrophic scars: a comprehensive review. , 1989, Plastic and reconstructive surgery.

[23]  W. Sahl,et al.  CUTANEOUS SCARS: PART II , 1994, International journal of dermatology.

[24]  S. Jimenez,et al.  Alterations in the regulation of expression of the αl(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma) , 2000, Springer Seminars in Immunopathology.

[25]  F. Wood,et al.  [International clinical recommendations on scar management]. , 2002, Zentralblatt fur Chirurgie.

[26]  L. Nanney,et al.  Chemokine and chemokine receptor expression in keloid and normal fibroblasts , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[27]  Ardeshir Bayat,et al.  Genetic Susceptibility to Keloid Disease and Hypertrophic Scarring: Transforming Growth Factor &bgr;1 Common Polymorphisms and Plasma Levels , 2003, Plastic and reconstructive surgery.

[28]  D. D. Datubo-Brown.  Keloids: a review of the literature. , 1990, British journal of plastic surgery.

[29]  G. Saed,et al.  Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. , 1998, Archives of dermatology.

[30]  L. Ciarmiello,et al.  Molecular characterization and expression of p63 isoforms in human keloids , 2004, Molecular Genetics and Genomics.

[31]  W. Jung,et al.  Studies on human scar tissue proteoglycans. , 1985, The Journal of investigative dermatology.

[32]  I. K. Cohen,et al.  Morphological and immunochemical differences between keloid and hypertrophic scar. , 1994, The American journal of pathology.

[33]  W C Grabb,et al.  Keloids and hypertrophic scars. , 1967, University of Michigan Medical Center journal.

[34]  P. Puddu,et al.  Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. , 1999, Journal of dermatological science.

[35]  A. Desmoulière,et al.  Fibrillin‐1 and elastin are differentially expressed in hypertrophic scars and keloids , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[36]  I. Ono,et al.  Enhanced Expression of Caspase-3 in Hypertrophic Scars and Keloid: Induction of Caspase-3 and Apoptosis in Keloid Fibroblasts In Vitro , 2000, Laboratory Investigation.

[37]  I. K. Cohen,et al.  Keloids and Hypertrophic Scars: A Comprehensive Review , 1991 .

[38]  T. Tuan,et al.  Role of Growth Factors in Scar Contraction: An In Vitro Analysis , 1996, Annals of plastic surgery.